AIM 2026-05-05|本週新刊導讀
note journal-summary public internal_medicinejournal_reading_guidecardiologynephrologyDKDanticoagulationDOACatrial_fibrillationhypertensionHPVcervical_cancerpreventionasthmaguidelineGRADEQUADASlong_COVIDmigrainebereavementaddiction_medicinebuprenorphine Physician
給專業人員 期刊摘要
最後審閱 2026-05-06 9 分鐘
AIM 2026-05-06 期刊導讀
本期共 54 篇 ,其中 22 篇 open access / free 。
本期主軸
本期最值得先讀的是 篩檢策略個人化 、COVID/long COVID 治療證據更新 、藥物交互作用安全訊號 、以及 基層照護指南 。整體訊息偏務實:許多看似合理的介入,例如穩定支撐鞋治療髖關節退化、metformin 或 UDCA 治療既有 long COVID,並未在臨床試驗中顯示明確效益;相對地,篩檢與用藥決策更強調風險分層與避免過度介入。
必讀文章導讀
1. 髖關節退化:穩定支撐鞋不優於平底柔軟鞋
Stable Supportive Footwear for Self-managing Hip Osteoarthritis Pain — A Randomized Clinical Trial
這項 120 人、6 個月隨機試驗比較「穩定支撐鞋」與「平底柔軟鞋」對髖關節退化疼痛的效果。主要結果未顯示穩定支撐鞋較佳;行走髖痛改善差異為 −0.5 分,信賴區間跨過無效值。臨床重點是:鞋款可作為自我管理選項,但不宜把「支撐性」直接等同於較佳止痛效果。值得注意的是,穩定支撐鞋組不良事件較少。
2. Long COVID:metformin 與 UDCA 治療既有 PASC 未勝過安慰劑
韓國兩家醫學中心 396 人的雙盲隨機試驗顯示,2 週 metformin 或 UDCA 治療,8 週後 PASC recovery 率與安慰劑相近:metformin 63.6%、UDCA 68.2%、安慰劑 68.2%。這篇的臨床意義是:急性感染期 metformin 可能與 long COVID 預防有關的假說,不能直接外推到「治療已成立的 PASC」。研究也凸顯 PASC outcome measure 與安慰劑/自然恢復效應的挑戰。
3. 高密度乳房補充 MRI:不是「密度高就做」,而是要納入乳癌風險
這是一篇模擬研究,評估 DBT 乳房攝影加上針對極高乳房密度者的補充 MRI。主要訊息是:對 extremely dense breasts 且乳癌相對風險 ≥2 的族群,補充 MRI 的 harm–benefit ratio 可能接近可接受範圍;但成本效益高度受 MRI 費用與偽陽性切片率影響。臨床上,這篇支持「乳房密度 + 個人風險」而非單靠密度做決策。
4. HPV 疫苗後的子宮頸癌篩檢:可能需要大幅減少頻率
Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus
挪威模型研究顯示,對 30 歲前已接種 HPV 疫苗的女性,成本效益較佳的 HPV-based screening 策略通常比現行 5 年一次更稀疏。對 12–24 歲接種者,偏好的策略約為每 15–25 年篩檢一次,一生 2–3 次。這篇的重點不是立即改變所有篩檢政策,而是指出疫苗時代的子宮頸癌風險已變,篩檢制度應開始依「接種年齡與疫苗種類」重新設計。
5. 懷孕早期血紅素:過低與偏高都與新生兒不良結果相關
Hemoglobin Concentration in Early Pregnancy and Severe Neonatal Morbidity and Mortality
加拿大 Ontario 超過 110 萬單胎妊娠的族群研究發現,懷孕 2–12 週血紅素與 severe neonatal morbidity and mortality 呈 U 型關係。相對於 125 g/L,90 g/L 與 150 g/L 均與較高風險相關。這提醒臨床上不只是處理貧血,也要注意相對紅血球增多或血液濃縮背後可能代表的風險;但這是觀察性研究,鐵劑補充與矯正目標仍需 RCT。
6. AF 使用 apixaban/rivaroxaban:合併 diltiazem 比 metoprolol 出血風險高
這篇美國行政資料庫研究比較 AF 患者使用 apixaban 或 rivaroxaban 時,合併 diltiazem 或 metoprolol 的出血風險。配對後每組 23,000 人,diltiazem 與較高 serious bleeding 住院風險相關,且 >120 mg/day 的高劑量風險更明顯。臨床含義:若病人使用 factor Xa inhibitor,rate control 選擇 diltiazem 時要重新評估出血風險、劑量與替代方案。
指南、綜論與方法學更新
| 主題 | 文章 | 導讀 |
|---|---|---|
| COVID-19 門診抗病毒治療 | Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review OA | 最終版 rapid review;nirmatrelvir–ritonavir、molnupiravir、simnotrelvir–ritonavir 對恢復時間或恢復率有不同程度證據,副作用與證據確定性需納入決策。 |
| ACP COVID practice points | Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults OA | 建議高風險、症狀 5 天內、輕中度 COVID 可考慮 nirmatrelvir–ritonavir 或 molnupiravir;不建議 ivermectin 或 sotrovimab。 |
| 喪親照護 | Care of Bereaved Persons — A Systematic Review OA | 169 個 RCT;成人個別心理治療對 grief disorder、悲傷與憂鬱症狀有較可信效益,兒童與文化特異介入證據仍薄弱。 |
| 氣喘基層照護 | 2025 VA/DOD Asthma Guideline Synopsis OA | 強調 inhaled corticosteroids,並支持 ICS + rapid-onset LABA 作為 reliever/controller 的簡化策略;也納入 GERD、肥胖與專科轉介決策點。 |
| 診斷準確性研究評讀 | QUADAS-3 OA ;QUADAS-3 Explanation and Elaboration OA | QUADAS-2 的新版工具,針對 diagnostic test accuracy systematic review 的 bias 與 applicability 評估提供更新架構。 |
| GRADE 方法學 | New GRADE Evidence-to-Decision Framework OA | 把 GRADE EtD 從 pairwise comparison 擴展到 multiple comparisons,對 network meta-analysis 與多選項 guideline 制定特別重要。 |
| 住院肝硬化 | Inpatient Management of Patients With Cirrhosis | 更新肝硬化住院照護,涵蓋出血、感染、腹水、腎損傷等常見高風險問題。 |
臨床可帶走的 5 點
- 不要把機轉合理等同於臨床有效。 支撐鞋治療髖 OA、metformin/UDCA 治療既有 PASC 都是負向或中性試驗。
- DOAC 病人的 rate control 需注意交互作用。 Apixaban/rivaroxaban 合併 diltiazem,尤其高劑量,可能增加 serious bleeding。
- 篩檢正走向個人化。 乳癌補充 MRI 要看乳房密度與整體風險;HPV 疫苗後子宮頸癌篩檢可能要依接種年齡下修頻率。
- COVID 門診治療重點仍是早期、高風險、抗病毒。 ACP practice points 保留 nirmatrelvir–ritonavir 與 molnupiravir 的角色,同時明確排除 ivermectin 與 sotrovimab。
- 照護「非疾病本身」的證據正在補強。 喪親照護、醫師稱謂、LLM 用於心理治療、primary care mastery 等文章,反映 AIM 本期不只處理藥物與篩檢,也處理照護關係與專業倫理。
完整文章連結
Original Research
- Stable Supportive Footwear for Self-managing Hip Osteoarthritis Pain — A Randomized Clinical Trial
- Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 — A Randomized Clinical Trial OA
- Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk
- Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus
- Hemoglobin Concentration in Early Pregnancy and Severe Neonatal Morbidity and Mortality
- The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol
Reviews / Methods / Guidelines
- Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review OA
- Care of Bereaved Persons — A Systematic Review OA
- QUADAS-3: A Revised Tool for the Quality Assessment of Diagnostic Test Accuracy Studies OA
- QUADAS-3 Explanation and Elaboration OA
- Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: ACP Practice Points OA
- A Synopsis of the 2025 VA/DOD Asthma Clinical Practice Guideline OA
- How Would You Manage This Patient With Frequent Migraine Headaches?
- Physicians Are Not Providers: The Ethical Significance of Names in Health Care OA
- New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons OA
Ideas, Opinions, Editorials
- The Case Against Six-Month Limits on Buprenorphine Telehealth Prescribing
- Dietary Guidelines: Tilting From Treatment Toward Prevention
- Use of Large-Language Models for Therapy: Promise and Perils
- Advancing Clinical Mastery: An Essential Element of Primary Care Revitalization
- Supplemental Magnetic Resonance Imaging in Breast Cancer Screening
- Adapting Cervical Cancer Screening in Vaccinated Populations
- Small Acts of Compassion: What Current Evidence Does Not Measure
- A New Approach to Reliever Therapy in Asthma
Humanities / Clinic / News
- Suffering and Redemption
- Correction: Chronic Coronary Artery Disease
- Correction: Burnout Interventions Among Health Care Professionals
- A Glimpse of the Divine
- Inpatient Management of Patients With Cirrhosis
- Are plastics, once our future, headed for the past?
- Q&A: Choosing shoes for osteoarthritis pain
- Q&A: LLM use for mental health prompts call for caution
- Danger can lurk in liver supplements
- Cardiologists weigh in on medications for obesity
ACP Journal Club
- Pregabalin does not differ from duloxetine for painful diabetic neuropathy
- ADHD: atomoxetine, methylphenidate, and CBT reduce symptom severity
- Polymyalgia rheumatica: weekly methotrexate improved glucocorticoid-free remission
- After ischemic stroke on aspirin, switching antithrombotic regimen did not reduce recurrence
- MINOCA: cause-guided stratified treatment improved angina status
- BP-lowering drugs reduced major CV events similarly with or without isolated diastolic hypertension
- Type 1 diabetes with overweight/obesity: GLP-1 RAs reduce weight, HbA1c, and insulin dose
- Sepsis: tailored precision immunotherapy improved organ function at 9 days
- Chronic lung disease: 4 PE diagnostic strategies assessed
- ED DVT rule-out: Wells score plus age-adjusted D-dimer had failure rate ≤0.8%
Web Exclusives / Patient Summaries
- Annals Consult Guys — A Landscaper With Abdominal Pain OA
- Annals Graphic Medicine — If Care Came in Doses OA
- Annals Graphic Medicine — The Last Thing a Nocturnist Wants to Hear Before Shift Change OA
- Annals for Educators — April 2026 OA
- Annals On Call — Managing Hyponatremia Part 2 OA
- Annals On Call — Physicians Not Providers OA
- Annals Video Summary — Outpatient Treatment of Confirmed COVID-19
- Annals Video Summary — Care of Bereaved Persons
- Summary for Patients: VA/DOD Asthma Clinical Practice Guideline
- Summary for Patients: Optimizing Cervical Cancer Screening by HPV Vaccination Age
- Summary for Patients: Stable Supportive Footwear for Hip Osteoarthritis Pain